BPC-157 vs KPV
The two peptides people name together when the gut stops cooperating, one studied for repair and one for calming inflammation, and both sold as capsules.
BPC-157 or KPV?
Choose BPC-157 if
The gut is one item on a longer repair list, say a stomach that's grown unpredictable plus a knee or shoulder that healed partway and stalled, and you'd like the peptide with the deeper animal research behind it.
Choose KPV if
The gut is the whole story: flares, bloating, foods that suddenly don't sit right, and you want the one studied for calming an inflamed colon, by capsule or by injection.
Or both. You want repair and calm at the same time. People run them as two products on their own schedules, or as the premixed KLOW blend, which is injected and adds GHK-Cu and TB-500.
BPC-157 and KPV, side by side
BPC-157 injected amounts are the patterns on vendor and telehealth education pages, and its capsule amount comes from clinician and vendor literature for digestive use. KPV amounts are vendor and community convention. No label or human study sets any of them, and all match our dosage pages.
The difference, in plain words
A gut that flares, bloats or stopped tolerating foods it handled for years is what brings most people to these two names, and they're the two peptides mentioned together for it most. They aren't really rivals, they're two ideas about the same problem, with BPC-157 described in terms of repair and KPV in terms of calming inflammation.
BPC-157 is a lab-made copy of a 15-amino-acid stretch of a protective protein found in stomach juice. It started out as a stomach-protection peptide, and in a large body of animal research it sped up healing of the gut lining, tendons and muscle, which is why it's also the one people take for a knee that stalled. It holds up in stomach acid in lab and animal work, so it comes as an oral capsule for gut use, though nobody has measured how much a person absorbs that way. Our answer on whether BPC-157 works orally has the detail.
KPV is just three amino acids, snipped from the end of alpha-MSH, a hormone your body already uses to calm inflammation, without the part that tans skin. If alpha-MSH is a long instruction, KPV is the last three words, the ones that say "calm down," which seems to work better on a colon than it ever has in the group chat. Its research is in mice and lab dishes, mostly on the inflamed colon, where gut lining cells pulled it inside through a kind of loading dock that gets busier when tissue is inflamed. That's the reason swallowing it is even on the table.
The split, repair for one and calm for the other, comes from each peptide's own animal work, not from any study comparing them in people. If the gut is part of a wider healing goal, our healing and repair page lists everything else people look at, and BPC-157 vs TB-500 covers the injury side of BPC-157.

Dosage side by side
| BPC-157 dosage chart by route | KPV dosage chart by route | |
|---|---|---|
| Amount | 250–500 mcg per injection | 250–500 mcg injected; capsule 500 mcg–1 mg |
| Timing | 1–2 times a day oral: once, empty stomach | Once a day capsule on an empty stomach |
| Course | 4–8 weeks 2–12 weeks across sources | 4–8 weeks then a break |
| Route | Under the skin or oral capsule | Under the skin or capsule for the gut |
BPC-157 dosage chart by route dosage guide → · KPV dosage chart by route dosage guide →
| Pattern | BPC-157 | KPV |
|---|---|---|
| Capsule, for the gut | 500–1,000 mcg once a day, 4–12 weeks | 500 mcg–1 mg once a day |
| Capsule timing | Empty stomach | Empty stomach |
| Injected, most common | 250–500 mcg, 1–2 times a day, 4–8 weeks | 250–500 mcg once a day, 4–8 weeks |
| After the course | No study or label sets a break | A break, length not set |
| Injected, split | 250–350 mcg twice a day, 30 days | No separate pattern |
| Injected, once daily | 500–700 mcg a day, 30 days | Same as most common |
| Fresh injury | 250–500 mcg twice a day, 2–4 weeks | No separate pattern |
| Long-running issue | 200–300 mcg a day, 4–12 weeks | No separate pattern |
| In studies | Enema in colitis, doses never fully published | Drinking water in mice, no human amount |
Where these come from: the BPC-157 capsule amount comes from clinician and vendor literature for digestive use, in the arginate salt form (a version sold as more stable in the stomach than the acetate form in most vials), and its injected amounts are the patterns on vendor and telehealth education pages and community protocol write-ups, none traced to a clinician or study. The KPV amounts, timing and course are vendor and community convention with no named clinician or study behind them. No label or human dosing study sets any figure for either. The units to draw and how long a vial lasts are on the BPC-157 dosage chart and the KPV dosage chart.
On both sides the capsule amount is a separate convention, not the injected amount taken by mouth, so the numbers don't convert between routes. For KPV it's set higher on the reasoning that some is lost in digestion.
Taking BPC-157 and KPV together
This is the gut pairing people describe most, and "KPV and BPC-157" is one of the first things search suggests after KPV's name. The thinking is that BPC-157 works on repair while KPV turns down the inflammation around it. That's reported practice from vendor and community sources, and no study tests the two together.
As separate injections, people run each on its own chart over the same weeks, KPV once a day and BPC-157 once or twice a day, one after the other. People search for the pair as capsules too, and no study or label sets a combined capsule schedule, so each capsule's own amount is what people go by.
The premixed option is the KLOW blend, and it's more than the pair. The listings we track give it as a 5:1:1:1 mix, most often 50 mg of GHK-Cu with 10 mg each of BPC-157, TB-500 and KPV in an 80 mg vial. It's injected only, which means the capsule-for-the-gut reasoning doesn't carry over to it. No label, listing or study gives an amount for KLOW, and the KLOW blend dosage page shows the math on its fixed split: a 2 to 4 mg draw contains 250 to 500 mcg each of BPC-157 and KPV, inside each one's usual injected range, along with the TB-500 and GHK-Cu. If the gut is your main reason and skin and joints aren't on the list, the two on their own are the more direct buy.
BPC-157 and KPV prices
- Double R Labs10 mg · $24.99 $2.50/mg
- Evolve BioPep10 mg · $25.00 $2.50/mg
- Luvaminos10 mg · $25.00 $2.50/mg
- Alpha Peptides10 mg · $27.29 $2.73/mg
- Profound Aminos20 mg · $55.00 $2.75/mg
- Evolve BioPep10 mg · $20.00 $2.00/mg
- Alpha Peptides10 mg · $26.51 $2.65/mg
- Flawless Compounds10 mg · $26.95 $2.69/mg
- Glow Aminos10 mg · $26.95 $2.69/mg
- Peptide Club40 mg · $120.00 $3.00/mg
Compare both in the app. Compare the real price per milligram against what a whole course uses rather than the price of one vial, and check KLOW against buying the two separately. The vendors we track for BPC-157 sell it as vials of powder, so BPC-157 capsules mean shopping elsewhere, and few sellers test capsules the way they test vials. Look for third-party purity and identity testing on the batch, and check whether a capsule's report covers the finished capsule or only the powder that went into it. Vendors on PPL carry confidence labels, from High confidence to New vendor, and our guide to reading a certificate of analysis walks through what to check.
Side effects compared
BPC-157: no study has measured its safety in people, so there's no side-effect list at the amounts people use. What people report most is brief redness or irritation where they injected, and new digestive symptoms are reported more often with the oral form on an empty stomach. Some describe anxiety, heart palpitations or low mood, and nobody knows whether the peptide or a badly made vial is behind those. In its July 2026 briefing, FDA staff flagged clotting and liver signals in month-long rat and dog studies. Our answer on BPC-157 side effects goes through them.
KPV: no human safety study has been published. What people report is mostly digestive upset that starts or gets worse, a reaction where they injected such as redness or a small lump, and a headache or tiredness in the first week. People usually drop the amount or stop if it carries on. Those are reported experiences, not study findings.
Because BPC-157 encouraged new blood vessel growth in animal work, people with a history of cancer are usually told to be careful with it, a caution drawn from how it works rather than from cases. Nobody knows how KPV behaves alongside medications for bowel disease, so anyone with a diagnosed condition like Crohn's or ulcerative colitis is in untested territory with it. There's no information on pregnancy or breastfeeding for either, and no human study of the two together. BPC-157 is on the World Anti-Doping Agency's banned list, so anyone tested in sport should treat it as prohibited.
Both are sold for research, and the big human trials haven't been run yet. You knew that, it's why you're reading this and not the label.
BPC-157 and KPV prices today
Questions people ask
BPC-157 vs KPV for gut health, which is better?
Neither has been tested against the other, or in a proper trial for gut symptoms in people. People lean toward KPV when inflammation and flares are the whole problem, and toward BPC-157 when the gut sits alongside an injury that needs repair.
Can you take BPC-157 and KPV together?
People do, and it's the gut pairing described most often, with each run at its own dosage page amount. No study tests the two together, and the premixed version, the KLOW blend, also contains GHK-Cu and TB-500.
Can you take BPC-157 and KPV orally?
Both are sold as capsules for the gut, which is unusual for peptides. BPC-157 holds up in stomach acid in lab and animal work, and gut cells in mice pulled KPV in through a transporter, but nobody has measured how much of either a person absorbs by mouth.
What's the difference between BPC-157 and KPV dosage?
Injected, both are usually 250 to 500 mcg, BPC-157 once or twice a day and KPV once a day. By capsule, both run higher, about 500 to 1,000 mcg a day on an empty stomach, from clinician and vendor literature for BPC-157 and vendor and community convention for KPV, with no label or human study behind either.
What are the side effects of BPC-157 and KPV?
Neither has a measured side-effect list in people. People report brief redness where they injected for both, new digestive symptoms with oral BPC-157, and digestive upset, injection reactions or an early headache with KPV.
Is there a blend with BPC-157 and KPV?
Yes, the KLOW blend, which is BPC-157, KPV, TB-500 and GHK-Cu in one injectable vial. No label, listing or study gives an amount for it, and the fixed ratio means you can't raise one without the others.
